A common inquiry to a supplement manufacturer is simple:
“I have the formula, but there are too many ingredients to fit into one capsule. What should we do?”
This is not only a capsule-size problem.
When a botanical formula contains multiple extracts, nutrients, and supporting ingredients at meaningful daily amounts, the total powder load can quickly exceed the practical capacity of a capsule.
For an OEM or private-label supplement project, the formula therefore needs to be evaluated as a complete manufacturing system.
Key variables include:
The objective is not simply to fit more ingredients into a capsule. It is to develop a formula that is technically manufacturable, commercially practical, and suitable for the target market.
A formula can look reasonable on paper but become difficult during actual production.
For example, a formula may contain:
Each ingredient contributes to the total daily powder load.
The practical question is therefore:
Can the required daily amount be delivered in a reasonable number and size of capsules?
A formula with a high total load may require:
For this reason, capsule capacity should be reviewed during formulation development rather than after the formula has already been finalized.
Capsules are available in different sizes, but a larger capsule does not automatically solve a high-load formulation problem.
The actual amount of powder that can be filled depends on the relationship between:
A high-density powder may fit a greater mass into the same capsule volume than a low-density botanical powder.
Therefore, capsule size should not be selected based only on ingredient weight.
For high-load botanical formulas, bulk density is one of the most important physical variables.
Two formulas with the same powder weight can occupy very different capsule volumes because their bulk density and packing behavior may differ.
A preliminary fill-weight estimate can be made using:
Estimated Fill Weight (mg) ≈ Capsule Volume (mL) × Tapped Density (g/mL) × 1000
For example, if a formulation has a tapped density of 0.5 g/mL, a capsule with an approximate internal volume of 0.9 mL would theoretically hold around 450 mg under the assumed packing condition.
This is a formulation-estimation method rather than a guaranteed production fill weight. Actual filling performance depends on powder characteristics, formulation composition, tamping conditions, equipment and process settings.
Capsule-volume and fill-weight values are preliminary formulation estimates only. Actual capacity should be verified using the intended capsule shell, finished powder blend and production filling equipment.
Capsule Size
Approx. Internal Volume*
At 0.4 g/mL
At 0.5 g/mL
At 0.6 g/mL
Size 00
~0.95 mL
~380 mg
~475 mg
~570 mg
Size 0
~0.68 mL
~270 mg
~340 mg
~410 mg
Size 1
~0.50 mL
~200 mg
~250 mg
~300 mg
*Approximate values for formulation planning only. Actual capsule capacity varies by capsule shell specification, internal volume, powder characteristics and filling conditions.
This comparison illustrates why botanical extract fill weight cannot be determined from ingredient weight alone.
For high-load botanical capsule projects, the practical development sequence is:
Total Daily Powder Load → Target Fill Weight → Capsules per Serving → Capsule Size → Filling Feasibility
The formula should therefore be evaluated using actual ingredient specifications and physical properties before the final capsule configuration is confirmed.
A common formulation mistake is to focus only on capsule size. In commercial product development, the daily capsule count is equally important.
A formula may technically fit by using larger capsules or four, five, or more capsules per serving, but this can affect consumer convenience, packaging and cost.
The OEM development team should therefore evaluate:
Variable
Manufacturing Consideration
Total daily dosage
Determines total powder load
Bulk density
Determines occupied capsule volume
Capsule size
Determines physical capacity
Capsules per serving
Affects consumer usability
Fill weight
Affects filling consistency
Formula complexity
Affects blending and processing
Packaging
Must accommodate final serving configuration
The goal is to find a practical balance rather than maximize the number of ingredients.
One way to improve capsule feasibility is to review the specification of the botanical ingredients.
When botanical extracts contribute significantly to total fill weight, extract concentration should be reviewed together with dosage, specification, cost and manufacturing behavior.
Instead of using a relatively low-strength botanical powder at a high dosage, the formulation may sometimes use a more concentrated or standardized extract where technically and commercially appropriate.
Possible specification options include:
The important point is that higher concentration does not automatically mean better.
The selected ingredient must also be evaluated for:
A more concentrated specification may reduce powder loading but can also increase raw-material cost, so extract selection should be evaluated as part of the overall formula economics.
Excipients can help improve manufacturing performance, but they also occupy formulation space.
Depending on the ingredients and dosage form, excipients may be considered for:
However, adding excipients does not create additional capsule capacity.
In a high-load formula, excessive excipient requirements can actually make the capacity problem worse.
This is why the formulation sequence should be:
Active ingredient load → Physical properties → Manufacturing behavior → Excipients → Final capsule configuration
rather than simply adding excipients after the formula becomes difficult to fill.
A formula can have an acceptable theoretical fill weight but still be difficult to manufacture if the powder does not flow consistently.
Relevant physical properties may include:
Poor flowability can contribute to:
For multi-ingredient botanical formulas, flow behavior should therefore be reviewed during formulation development.
The objective is not only to make the formula fit inside the capsule, but to ensure that it can be reliably processed and filled at production scale.
High-load formulas often contain ingredients with very different:
This creates a potential segregation risk during material handling and blending.
A formulation containing one high-dose ingredient and several low-dose ingredients may require particular attention to:
Pilot-scale production can help verify whether the formulation behaves consistently under actual manufacturing conditions.
This is especially important when several botanical extracts are included at different dosage levels.
If the formula cannot reasonably fit into the selected capsule configuration, there are several possible solutions.
Option 1
A larger capsule may provide additional capacity.
However, this should be balanced against:
Option 2
Instead of increasing capsule size, the daily serving can be distributed across more capsules.
This may solve the manufacturing issue but can affect:
Option 3
Some ingredients may be available in more concentrated or standardized specifications.
This may reduce total powder load while maintaining the intended formulation architecture.
Option 4
Not every ingredient needs to remain in the final formula.
A technically possible formula is not necessarily the best commercial formula.
The development review should consider:
The next step may be to increase capsule size, increase the number of capsules, use more concentrated ingredients, simplify the formula, or consider an alternative dosage form.
Option 5
If the required daily powder load is too high for a practical capsule product, a powder, stick pack, tablet, or another dosage form may provide a better manufacturing solution.
The best dosage form is the one that works with the complete formula.
Dosage Form
High-Load Suitability
Key Considerations
Capsules
Moderate
Capsule volume, fill weight, daily capsule count
Tablets
Moderate
Compression, density, hardness, excipients
Powder
High
Serving size, taste, flowability, dispersibility
Stick Packs
High
Powder load, filling, moisture and packaging
Liquid
Formula-dependent
Solubility, stability, processing and packaging
Capsules remain an excellent option for concentrated botanical formulas.
However, they should not be treated as the default solution for every high-load formulation.
Before confirming the final capsule specification, the OEM manufacturer should conduct a manufacturing feasibility review covering the complete formula, dosage form and production requirements.
The purpose of this review is to identify manufacturing risks before commercial production is scheduled.
A high-load botanical formula may move through several development stages.
Used to evaluate:
A prototype does not necessarily prove commercial-scale manufacturing feasibility.
A pilot run provides an opportunity to evaluate:
After the formula and process are confirmed, commercial production can be planned around:
This staged approach helps reduce the risk of changing the formula after a commercial quotation has already been issued.
For high-load botanical capsule projects, MOQ is not determined only by the number of finished bottles.
The final commercial quotation may depend on:
Lead time may also change when:
Therefore, MOQ, cost and lead time should be reviewed together with formula feasibility rather than quoted from the ingredient list alone.
The final capsule configuration affects packaging requirements.
A product containing a high number of capsules per serving may require:
Packaging should therefore be evaluated after the dosage form and serving configuration are reasonably defined.
Key considerations include:
Packaging is part of the manufacturing specification, not simply a final design decision.
Target-market requirements should be reviewed before the formula and commercial specifications are finalized.
Key considerations may include:
Key considerations may include:
Key considerations may include:
Key considerations may include:
Key considerations may include:
The regulatory route should be confirmed against the final formula, dosage, product classification, claims and target market, rather than based on ingredient names alone.
When requesting an OEM feasibility review, provide:
The more complete the information, the more accurately a supplement manufacturer can assess the appropriate formulation and manufacturing route:
Formula feasibility → MOQ → Cost → Lead Time → Production Route
The formula does not necessarily need to be abandoned.
Sometimes, but not always.
It may.
Because the final manufacturing requirements may differ from the initial project assumptions.
Not necessarily.
Whether you choose standard China OEM or hybrid manufacturing, we’re here to support your nutraceutical brand development.
Share this page to